About Elicio Therapeutics, Inc. 
Elicio Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (3.44%)
Foreign Institutions
Held by 9 Foreign Institutions (1.33%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 224 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-2.60
-1,102.54%
58.67






